X-ZELL shortlisted for 2019 HealthInvestor Asia Award

X-ZELL shortlisted for 2019 HealthInvestor Asia Award Singapore, April 2019 – Rare cell detection specialist, X-ZELL, has been shortlisted as a Finalist for the 2019 HealthInvestor Asia Awards. According to HealthInvestor Asia, X-ZELL has been nominated in the...

X-ZELL Blog Episode 10

Episode 10 Think macro, act micro Less than two years after starting the transition from local research company into global enterprise, X-ZELL is about to celebrate our biggest milestone yet – the long-anticipated world premiere of the X-ZELL Cryoimmunostaining™...

X-ZELL welcomes new Brand Ambassadors

X-ZELL welcomes new Brand Ambassadors Singapore, February 2019 – In a move to support the forthcoming world premiere of the X-ZELL Cryoimmunostaining™ Suite, X-ZELL is proud to announce the appointment of Heinz Hildebrand and Troy Bailey as the company’s new Brand...

X-ZELL Blog Episode 9

Episode 9 Why prostate cancer screening is back on the agenda Largely unnoticed by the general public, early prostate cancer detection recently rose to the very top of the European Parliament’s teeming agenda. Coinciding with the European Prostate Cancer Awareness Day...